Clinical trials
Adenocarcinoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 4 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Active, not recruiting | 6 |
| Terminated | 6 |
| Not yet recruiting | 5 |
| Recruiting | 5 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 8 |
| AstraZeneca | 3 |
| Eli Lilly and Company | 3 |
| Abbott | 2 |
| Astellas Pharma Global Development, Inc. | 2 |
| Blueprint Medicines Corporation | 2 |
| Ontario Clinical Oncology Group (OCOG) | 2 |
| Ariad Pharmaceuticals | 1 |
| Astellas Pharma Europe Ltd. | 1 |
| Australasian Gastro-Intestinal Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 49 |
| Neoplasms | 18 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Carcinoma | 10 |
| Prostatic Neoplasms | 9 |
| Neoplasms by Site | 8 |
| Stomach Neoplasms | 8 |
| Digestive System Neoplasms | 7 |
| Lung Neoplasms | 7 |
| Neoplasms by Histologic Type | 7 |
Trials
Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.